← Browse by Condition
Medical Condition
pancreatic ductal adenocarcinoma
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 2
NCT07261631 Phase 1
Recruiting
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Enrollment
180 pts
Location
Canada, France, Isra...
Sponsor
Novartis Pharmaceuticals
NCT07226154
Recruiting
Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer
Enrollment
200 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT05296421
Recruiting
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Enrollment
16 pts
Location
United States
Sponsor
Rutgers, The State University ...
NCT06586515 Phase 1
Recruiting
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Enrollment
630 pts
Location
United States, Canad...
Sponsor
Eli Lilly and Company
NCT06445062 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Enrollment
1,130 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT07096362 Phase 2
Recruiting
Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
Enrollment
50 pts
Location
United States
Sponsor
University of Miami